A closer look on the battlefield: the salvaged area at risk as an outcome marker for myocardial reperfusion.
Friedrich
Matthias G
MG
D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects*; D003287:Contrast Media; D017023:Coronary Angiography; D006352:Heart Ventricles / Q000000981:diagnostic imaging / Q000473:pathology; D006571:Heterocyclic Compounds; D006801:Humans; D008279:Magnetic Resonance Imaging; D009203:Myocardial Infarction / Q000000981:diagnostic imaging* / Q000473:pathology* / Q000628:therapy; D017202:Myocardial Ischemia / Q000000981:diagnostic imaging / Q000209:etiology* / Q000473:pathology; D009206:Myocardium / Q000473:pathology*; D009942:Organometallic Compounds; D009943:Organophosphorus Compounds; D015609:Organotechnetium Compounds; D011237:Predictive Value of Tests; D019275:Radiopharmaceuticals; D015203:Reproducibility of Results; D018570:Risk Assessment; D013997:Time Factors; D015899:Tomography, Emission-Computed, Single-Photon; D016896:Treatment Outcome
D003287:Contrast Media; D006571:Heterocyclic Compounds; D009942:Organometallic Compounds; D009943:Organophosphorus Compounds; D015609:Organotechnetium Compounds; D019275:Radiopharmaceuticals; C078700:technetium tc-99m tetrofosmin; C050823:gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate